Trial Profile
Evaluation of silodosin versus tadalafil in patients with urination disorders associated with benign prostatic hyperplasia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Mar 2017
Price :
$35
*
At a glance
- Drugs Silodosin (Primary) ; Tadalafil
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Sponsors Kissei Pharmaceutical
- 29 Mar 2017 Status changed from recruiting to completed.
- 25 Aug 2015 New trial record